Haemophilia

Results: 564



#Item
1AISBL European Haemophilia Consortium (EHC) NoRue de l’Industrie/ Nijverheidsstraat 10, 1000 Brussels, Belgium Tel. +70; Email: ; Website: www.ehc.eu EHC Response to the Publi

AISBL European Haemophilia Consortium (EHC) NoRue de l’Industrie/ Nijverheidsstraat 10, 1000 Brussels, Belgium Tel. +70; Email: ; Website: www.ehc.eu EHC Response to the Publi

Add to Reading List

Source URL: www.cslbehring.at

- Date: 2016-07-05 06:52:22
    2News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

    News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

    Add to Reading List

    Source URL: www.cslbehring.at

    Language: English - Date: 2013-11-18 05:52:30
    3NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript

    NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript

    Add to Reading List

    Source URL: www.ncbi.nlm.nih.gov

    Language: English
    4News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

    News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

    Add to Reading List

    Source URL: www.cslbehring.at

    Language: English - Date: 2013-11-18 05:52:29
    5News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

    News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

    Add to Reading List

    Source URL: www.cslbehring.at

    Language: English - Date: 2013-11-18 05:52:29
    6Life Cycle Management ensures continuous improvement of existing products. Marketplace

    Life Cycle Management ensures continuous improvement of existing products. Marketplace

    Add to Reading List

    Source URL: www.csl.com.au

    Language: English - Date: 2015-11-25 04:27:21
    7For immediate release 26 May 2016 AFSTYLA® (rFVIII-Single Chain) – FDA approval CSL Limited (ASX:CSL; USOTC:CSLLY) - CSL today announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® [Antihaemo

    For immediate release 26 May 2016 AFSTYLA® (rFVIII-Single Chain) – FDA approval CSL Limited (ASX:CSL; USOTC:CSLLY) - CSL today announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® [Antihaemo

    Add to Reading List

    Source URL: www.csl.com.au

    Language: English - Date: 2016-05-25 20:22:52
    8HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR

    Add to Reading List

    Source URL: labeling.cslbehring.com

    Language: English - Date: 2016-05-26 14:29:43
    9HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IDELVION® safely and effectively. See full prescribing information for IDELVION. --------------------------------DO

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IDELVION® safely and effectively. See full prescribing information for IDELVION. --------------------------------DO

    Add to Reading List

    Source URL: labeling.cslbehring.com

    Language: English - Date: 2016-03-15 15:43:12
    10Microsoft Word - Tribunal News 27

    Microsoft Word - Tribunal News 27

    Add to Reading List

    Source URL: www.haemophilia.ie

    Language: English - Date: 2013-02-26 06:38:13